Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Norman David Eansor currently holds 2,117 shares of Marker Therapeutics, Inc. (MRKR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Norman David Eansor has been a net seller of MRKR stock. They have purchased $250.0K and sold $37.4M worth of shares.
Norman David Eansor's most recent insider trade was on Nov 16, 2021, when they sold 799 shares at $125.05 per share.
Norman David Eansor serves as Executive at Marker Therapeutics, Inc. (MRKR). They have executed 58 insider transactions totaling $37.7M over their tenure at the company.
Norman David Eansor holds the position of Executive at Marker Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
Norman David Eansor has shown a selling trading pattern, with $250.0K in total purchases and $37.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Norman David Eansor was on Feb 5, 2021, when they sold $4.9M worth of TECH shares. This transaction involved 12,833 shares at $380.50 per share.
Norman David Eansor currently owns 2,117 shares of Marker Therapeutics, Inc. (MRKR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Norman David Eansor's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Norman David Eansor has 58 Form 4 filings on record as an insider at Marker Therapeutics, Inc..
Set alerts for Norman David Eansor and 40,000+ other insiders.